Expand DCTH Menu
DCTH MENU

DCTH Latest Press Releases

-- May 26, 2026 --

Delcath Systems Announces Two ASCO 2026 Investigator Initiated Trials-in-Progress Abstracts Business Wire 4:01 PM

-- May 15, 2026 --

Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:01 PM

-- May 12, 2026 --

Delcath Systems to Participate at the H.C. Wainwright 4th Annual BioConnect Investor Conference Business Wire 8:00 AM

-- May 7, 2026 --

Delcath Systems Reports First Quarter 2026 Results and Business Highlights Business Wire 8:00 AM
Delcath Systems Announces Presentation of New Data on Percutaneous Hepatic Perfusion with Melphalan in Liver-Dominant Metastatic Breast Cancer at ESMO Breast Cancer 2026 Business Wire 7:00 AM

-- April 23, 2026 --

Delcath Systems to Host First Quarter 2026 Earnings Call Business Wire 8:30 AM

-- April 6, 2026 --

Delcath Systems, Inc. Announces Inclusion of CHEMOSAT Hepatic Delivery System for Melphalan as a Recommended Liver-Directed Regional Therapy Option in the ESMO-EURACAN Clinical Practice Guidelines for Uveal Melanoma Business Wire 8:30 AM

-- April 1, 2026 --

Delcath Systems to Participate at the Society of Interventional Radiology 2026 Meeting Business Wire 8:30 AM

-- March 3, 2026 --

Delcath Systems Announces Publication of CHOPIN Clinical Trial Results in The Lancet Oncology Business Wire 8:00 AM

-- February 26, 2026 --

Delcath Systems Reports Fourth Quarter and Full Year 2025 Results Business Wire 8:00 AM

-- February 12, 2026 --

Delcath Systems to Host Fourth Quarter and Full Year 2025 Earnings Call Business Wire 8:00 AM
Market Data Delayed 15 Minutes